The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aceso Research Labs LLP
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aceso Research Labs LLP, part of the promoter group of Astal Laboratories Ltd, has disclosed a change in its shareholding under SEBI's Takeover Regulations. The promoter entity acquired 19,59,284 equity shares through a preferential allotment of convertible warrants and equity shares pursuant to a swap, dated 14 January 2026. After this acquisition, Aceso Research Labs LLP holds 18.19% of the total share/voting capital and 14.45% on a fully diluted basis. The company's total equity share capital expanded significantly from Rs. 10.77 crore (1.07 crore shares) to Rs. 42.22 crore (4.22 crore shares) as part of this preferential issuance.
This is a promoter-group acquisition through preferential allotment, which strengthens the promoter's stake in the company and signals confidence in the business. However, the promoter holding remains well below 50% at 18.19%, meaning the company is not promoter-dominated and is also subject to significant dilution from the expanded share base, which may be mildly negative for existing shareholders on a per-share basis.